UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $71,000 | -63.8% | 178,831 | -48.5% | 0.00% | – |
| Q2 2022 | $196,000 | -22.2% | 346,964 | +54.1% | 0.00% | – |
| Q1 2022 | $252,000 | -13.1% | 225,085 | +13.6% | 0.00% | – |
| Q4 2021 | $290,000 | +18.4% | 198,223 | +142.5% | 0.00% | – |
| Q3 2021 | $245,000 | -59.2% | 81,739 | -36.9% | 0.00% | – |
| Q2 2021 | $601,000 | -44.1% | 129,604 | -27.6% | 0.00% | – |
| Q1 2021 | $1,075,000 | +16.2% | 179,068 | +1.5% | 0.00% | – |
| Q4 2020 | $925,000 | +56.5% | 176,431 | +3.3% | 0.00% | – |
| Q3 2020 | $591,000 | -51.2% | 170,825 | +22.5% | 0.00% | – |
| Q2 2020 | $1,211,000 | +7.0% | 139,483 | -28.6% | 0.00% | -100.0% |
| Q1 2020 | $1,132,000 | -57.2% | 195,218 | -46.8% | 0.00% | 0.0% |
| Q4 2019 | $2,644,000 | +16.5% | 366,613 | -1.4% | 0.00% | 0.0% |
| Q3 2019 | $2,269,000 | +0.2% | 371,873 | +56.0% | 0.00% | 0.0% |
| Q2 2019 | $2,265,000 | +543.5% | 238,386 | +449.0% | 0.00% | – |
| Q1 2019 | $352,000 | +53.0% | 43,421 | +185.3% | 0.00% | – |
| Q2 2018 | $230,000 | – | 15,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mayo Clinic | 1,571,981 | $8,237,000 | 9.91% |
| Invus Financial Advisors, LLC | 1,094,998 | $5,738,000 | 2.40% |
| Founders Fund V Management, LLC | 491,751 | $2,577,000 | 0.66% |
| ALGERT GLOBAL LLC | 51,890 | $272,000 | 0.08% |
| Arbor Wealth Management, LLC | 25,888 | $136,000 | 0.05% |
| Moloney Securities Asset Management, LLC | 41,950 | $220,000 | 0.05% |
| PDT Partners, LLC | 78,800 | $413,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,957 | $2,070,000 | 0.02% |
| Fort Point Capital Partners LLC | 10,000 | $52,000 | 0.01% |
| Baillie Gifford | 3,803,014 | $19,928,000 | 0.01% |